Mometasone furoate-loaded cold processed oil-in-water emulsions: in vitro and in vivo studies. (June 2015)
- Record Type:
- Journal Article
- Title:
- Mometasone furoate-loaded cold processed oil-in-water emulsions: in vitro and in vivo studies. (June 2015)
- Main Title:
- Mometasone furoate-loaded cold processed oil-in-water emulsions: in vitro and in vivo studies
- Authors:
- Raposo, Sara
Tavares, Rita
Gonçalves, Lídia
Simões, Sandra
Urbano, Manuela
Ribeiro, Helena M. - Abstract:
- <abstract> <title>Abstract</title> <p>Over the years, research has focused on strategies to increase benefit/risk ratio of corticoids. However, vehicles intended for topical glucocorticoids delivery with an improved benefit/risk ratio are still on demand. The aim of this work was the <italic>in vitro</italic> and <italic>in vivo</italic> characterization of cold processed oil-in-water (o/w) emulsions intended for mometasone furoate (MF) delivery to induce drug targeting to upper skin strata, decreasing adverse effects. Two o/w emulsions, containing 0.1% of MF, were developed differing in the glycol used (2-methyl-2, 4-pentanediol – PT and ethoxydiglycol – TC emulsions). <italic>In vitro</italic> permeation studies revealed that these emulsions are suitable vehicles for the delivery of MF containing ingredients which are responsible for a drastically increased on the permeability coefficients of MF from a theoretical value of 1.18 × 10<sup>−4 </sup>cm/h to 5.20 × 10<sup>−4</sup> ± 2.05 × 10<sup>−4 </sup>cm/h and 6.30 × 10<sup>−4</sup> ± 2.94 × 10<sup>−4 </sup>cm/h, for PT and TC, respectively. The tape stripping results showed that the amount of drug that reached the viable skin layers was very low (1.99 %) and the amount that remained in the <italic>stratum corneum</italic> (SC) was 10.61%. The <italic>in vivo</italic> studies showed that the developed formulations decreased the edema and erythema in mice skin in more that 90%, assuring, at least, the same anti-inflammatory<abstract> <title>Abstract</title> <p>Over the years, research has focused on strategies to increase benefit/risk ratio of corticoids. However, vehicles intended for topical glucocorticoids delivery with an improved benefit/risk ratio are still on demand. The aim of this work was the <italic>in vitro</italic> and <italic>in vivo</italic> characterization of cold processed oil-in-water (o/w) emulsions intended for mometasone furoate (MF) delivery to induce drug targeting to upper skin strata, decreasing adverse effects. Two o/w emulsions, containing 0.1% of MF, were developed differing in the glycol used (2-methyl-2, 4-pentanediol – PT and ethoxydiglycol – TC emulsions). <italic>In vitro</italic> permeation studies revealed that these emulsions are suitable vehicles for the delivery of MF containing ingredients which are responsible for a drastically increased on the permeability coefficients of MF from a theoretical value of 1.18 × 10<sup>−4 </sup>cm/h to 5.20 × 10<sup>−4</sup> ± 2.05 × 10<sup>−4 </sup>cm/h and 6.30 × 10<sup>−4</sup> ± 2.94 × 10<sup>−4 </sup>cm/h, for PT and TC, respectively. The tape stripping results showed that the amount of drug that reached the viable skin layers was very low (1.99 %) and the amount that remained in the <italic>stratum corneum</italic> (SC) was 10.61%. The <italic>in vivo</italic> studies showed that the developed formulations decreased the edema and erythema in mice skin in more that 90%, assuring, at least, the same anti-inflammatory effect compared with the commercial cream. PT placebo demonstrated to contribute to restore the skin barrier by increasing the amount of lipids within the human skin.</p> </abstract> … (more)
- Is Part Of:
- Drug delivery. Volume 22:Number 4(2015:May)
- Journal:
- Drug delivery
- Issue:
- Volume 22:Number 4(2015:May)
- Issue Display:
- Volume 22, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 22
- Issue:
- 4
- Issue Sort Value:
- 2015-0022-0004-0000
- Page Start:
- 562
- Page End:
- 572
- Publication Date:
- 2015-06
- Subjects:
- Drug delivery systems -- Periodicals
Drug targeting -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/drd ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/10717544.2013.871086 ↗
- Languages:
- English
- ISSNs:
- 1071-7544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.104600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3091.xml